CCL5 and leukemia: However, inhibiting one of RANTES, IL2RA, NFAT, TNF, RAS, PLCG1, GRB2, IL2, and IL15 can decrease apoptosis, implying that they can facilitate cell survival and thereby cause drug resistance in the leukemia.